SI2066679T1 - Konjugati disorazolov in njihovi derivati z molekulami, ki vežejo celice, novi disorazolni derivati, postopki za njihovo izdelavo in njihova uporaba - Google Patents

Konjugati disorazolov in njihovi derivati z molekulami, ki vežejo celice, novi disorazolni derivati, postopki za njihovo izdelavo in njihova uporaba

Info

Publication number
SI2066679T1
SI2066679T1 SI200731775A SI200731775A SI2066679T1 SI 2066679 T1 SI2066679 T1 SI 2066679T1 SI 200731775 A SI200731775 A SI 200731775A SI 200731775 A SI200731775 A SI 200731775A SI 2066679 T1 SI2066679 T1 SI 2066679T1
Authority
SI
Slovenia
Prior art keywords
derivatives
disorazoles
conjugates
processes
cell
Prior art date
Application number
SI200731775A
Other languages
English (en)
Inventor
Eckhard Gunther
Olaf Schaefer
Michael Teifel
Klaus Paulini
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Publication of SI2066679T1 publication Critical patent/SI2066679T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SI200731775A 2006-09-06 2007-09-06 Konjugati disorazolov in njihovi derivati z molekulami, ki vežejo celice, novi disorazolni derivati, postopki za njihovo izdelavo in njihova uporaba SI2066679T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84235706P 2006-09-06 2006-09-06
EP06018750A EP1900742A1 (en) 2006-09-07 2006-09-07 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
PCT/EP2007/059310 WO2008028934A1 (en) 2006-09-06 2007-09-06 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
EP07803270.3A EP2066679B1 (en) 2006-09-06 2007-09-06 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof

Publications (1)

Publication Number Publication Date
SI2066679T1 true SI2066679T1 (sl) 2016-06-30

Family

ID=37670733

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200731775A SI2066679T1 (sl) 2006-09-06 2007-09-06 Konjugati disorazolov in njihovi derivati z molekulami, ki vežejo celice, novi disorazolni derivati, postopki za njihovo izdelavo in njihova uporaba

Country Status (16)

Country Link
US (3) US7741277B2 (sl)
EP (2) EP1900742A1 (sl)
KR (1) KR101532966B1 (sl)
AR (1) AR062685A1 (sl)
AU (1) AU2007293650B2 (sl)
CA (1) CA2662308C (sl)
DK (1) DK2066679T3 (sl)
ES (1) ES2572183T3 (sl)
HU (1) HUE028061T2 (sl)
MX (2) MX337358B (sl)
NZ (1) NZ575032A (sl)
PL (1) PL2066679T3 (sl)
RS (1) RS54857B1 (sl)
SI (1) SI2066679T1 (sl)
TW (1) TWI346116B (sl)
WO (1) WO2008028934A1 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1900742A1 (en) * 2006-09-07 2008-03-19 AEterna Zentaris GmbH Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
EP2340047A1 (en) * 2008-09-19 2011-07-06 Nektar Therapeutics Polymer conjugates of kiss1 peptides
WO2010033207A1 (en) * 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of therapeutic peptides
AU2010216372B2 (en) * 2009-02-20 2013-06-20 Ipsen Pharma S.A.S. Cytotoxic conjugates having neuropeptide Y receptor binding compound
US20120004182A1 (en) * 2010-07-02 2012-01-05 Carsten Gruendker Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells
CN110133300B (zh) * 2012-03-18 2022-02-25 镜株式会社 疾病样品分析装置、分析系统及分析方法
KR101974583B1 (ko) 2012-08-29 2019-05-02 삼성전자주식회사 링커 폴리펩티드 및 이를 이용한 표적 물질 분석 방법
US11465997B2 (en) 2017-06-22 2022-10-11 William Marsh Rice University Synthesis of disorazoles and analogs thereof as potent anticancer agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214969B1 (en) 1988-10-21 2001-04-10 The Administrators Of The Tulane Educational Fund Luteinizing hormone releasing hormone analogs with cytotoxic moiety
US5866679A (en) 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US5843903A (en) 1995-11-27 1998-12-01 The Administrators Of The Tulane Educational Fund Targeted cytotoxic anthracycline analogs
AU715632B2 (en) 1996-09-12 2000-02-03 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
DE19728737C1 (de) 1997-07-04 1999-02-11 Johannes Christian Groeninghen Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten
WO1999002175A1 (en) 1997-07-10 1999-01-21 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
UA79480C2 (en) * 2002-08-24 2007-06-25 Zentaris Gmbh Disorazol containing drug for treating benign and malignant tumors
US7364877B2 (en) 2002-12-06 2008-04-29 Kosan Biosciences, Inc. Polynucleotides encoding disorazole polyketide synthase polypeptides
AU2005244980B2 (en) * 2004-05-19 2011-09-15 E. R. Squibb & Sons, L.L.C. Chemical linkers and conjugates thereof
JP2008526246A (ja) 2005-01-13 2008-07-24 ヘルムホルツ−ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー ジソラゾールの産生のための合成経路をコードする遺伝子
US20060199252A1 (en) 2005-01-13 2006-09-07 Herbert Irschik Genes encoding the synthetic pathway for the production of disorazole
WO2006135371A1 (en) * 2005-06-09 2006-12-21 Kosan Biosciences Incorporated Conjugates with reduced adverse systemic effects
EP1743897A1 (en) * 2005-07-15 2007-01-17 Gesellschaft für Biotechnologische Forschung mbH Biologically active compounds obtainable from Sorangium cellulosum
EP1900742A1 (en) 2006-09-07 2008-03-19 AEterna Zentaris GmbH Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof

Also Published As

Publication number Publication date
US20100323963A1 (en) 2010-12-23
WO2008028934A8 (en) 2008-05-02
CA2662308C (en) 2014-10-28
CA2662308A1 (en) 2008-03-13
EP2066679B1 (en) 2016-03-09
KR20090064436A (ko) 2009-06-18
AR062685A1 (es) 2008-11-26
MX2009002483A (es) 2009-03-23
US8470776B2 (en) 2013-06-25
AU2007293650B2 (en) 2012-06-14
EP2066679A1 (en) 2009-06-10
HUE028061T2 (en) 2016-11-28
RU2009112546A (ru) 2010-10-20
RS54857B1 (sr) 2016-10-31
WO2008028934A1 (en) 2008-03-13
NZ575032A (en) 2011-02-25
PL2066679T3 (pl) 2016-09-30
US20080090758A1 (en) 2008-04-17
AU2007293650A1 (en) 2008-03-13
US20100317580A1 (en) 2010-12-16
KR101532966B1 (ko) 2015-07-02
ES2572183T3 (es) 2016-05-30
DK2066679T3 (en) 2016-06-27
MX337358B (es) 2016-02-29
TWI346116B (en) 2011-08-01
TW200823228A (en) 2008-06-01
EP1900742A1 (en) 2008-03-19
US7741277B2 (en) 2010-06-22

Similar Documents

Publication Publication Date Title
EP2395012B8 (en) Modified siRNA molecules and uses thereof
EP2067782A4 (en) HETERACENE DERIVATIVE, TETRAHALOTHERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME
AU2007313300A8 (en) Molecules with reduced half-lives, compositions and uses thereof
IL195245A0 (en) Substituted prolinamides, production thereof and their use as drugs
EP2268813A4 (en) RNA MOLECULES AND THEIR USE
IL195876A0 (en) Pyrazine derivatives with extended conjugation and uses thereof
HK1140202A1 (en) Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
IL218716A0 (en) Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof
IL189187A (en) Polymeric couplings of a252-k and their history, their pharmaceutical preparations and their uses
EP1990337A4 (en) CHINAZOLINE DERIVATIVES, METHOD OF MANUFACTURE AND USES THEREOF
TWI346116B (en) Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
ZA201001206B (en) Saccharide-containing protein conjugates and uses thereof
GB0808916D0 (en) Production of conjugates
IL206060A0 (en) Conjugates of anti-rg-1 antibodies, compositions comprising the same and uses thereof
EP2040242A4 (en) FOLDABLE LABEL, ARTICLE WITH FOLDABLE LABEL, AND METHOD OF MANUFACTURING THE ARTICLE
IL196866A (en) Erythropoietin compounds, pharmaceuticals containing them and their uses
ZA200900302B (en) Composition, article, its manufacture and use
IL195430A0 (en) Arylsulfonamidyl tetralin derivatives and uses thereof
HRP20160631T1 (hr) Konjugati disorazola i njihovi derivati sa staničnovezajućim molekulama, novi derivati disorazola, postupci njihove pripreme i njihove uporabe
ZA200901177B (en) Conjugates of disorazoles and their derivatives with cellbinding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
GB2469959B (en) Dioctatin derivatives and production process thereof
AU2007905753A0 (en) Novel Immunogenic Molecules and Uses Thereof
GB0616531D0 (en) The medicinal uses of molecules and their derivatives
ZA200808225B (en) Substituted prolinamides, production thereof and their use as drugs
GB0715513D0 (en) The medicinal uses of molecules and their derivatives